"For advanced, compassionate care for cancer and blood disorders, patients and their families have trusted St. Luke's Cancer Institute for more than 50 years. Today we are a network of five cancer centers dedicated to state-of-the-art treatment close to home; patient-centered care and support; cutting-edge research; and community prevention, education, and early detection initiatives. Our main cancer center in Boise brings you medical and radiation oncology specialists, as well as fellowship trained cancer surgeons in areas such as thoracic, hepatobiliary, gynecologic, and urologic oncology. We're also home to Idaho's only pediatric cancer program and federally sponsored hemophilia center."

During the past decade, Saint Luke's Cancer Institute - Boise conducted 213 clinical trials. In the 10-year time frame, 213 clinical trials started and 160 clinical trials were completed, i.e. on average, 75.1% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 76 clinical trials were completed. i.e. 120.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Luke's Cancer Institute - Boise" #1 sponsor was "National Cancer Institute (NCI)" with 163 trials, followed by "Children's Oncology Group" with 94 trials sponsored, "SWOG Cancer Research Network" with 66 trials sponsored, "Alliance for Clinical Trials in Oncology" with 38 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 38 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Luke's Cancer Institute - Boise" #1 collaborator was "National Cancer Institute (NCI)" with 255 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator and "Children's Oncology Group" with 7 trials as a collaborator. Other collaborators include 113 different institutions and companies that were collaborators in the rest 96 trials.

According to Clinical.Site data, the most researched conditions in "Saint Luke's Cancer Institute - Boise" are "Breast Cancer" (20 trials), "Recurrent Neuroblastoma" (18 trials), "Lymphoma" (16 trials), "Recurrent Osteosarcoma" (16 trials) and "Refractory Neuroblastoma" (15 trials). Many other conditions were trialed in "Saint Luke's Cancer Institute - Boise" in a lesser frequency.

Most popular intervention types in "Saint Luke's Cancer Institute - Boise" are "Drug" (345 trials), "Other" (235 trials), "Biological" (171 trials), "Procedure" (133 trials) and "Radiation" (90 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (116 trials), "Quality-of-Life Assessment" (77 trials), "Questionnaire Administration" (65 trials), "Biospecimen Collection" (55 trials) and "Computed Tomography" (52 trials). Other intervention names were less common.

The vast majority of trials in "Saint Luke's Cancer Institute - Boise" are 377 trials for "All" genders, 54 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Luke's Cancer Institute - Boise". undefined are not yet recruiting, 106 are recruiting, 168 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 137 completed trials in Saint Luke's Cancer Institute - Boise, 9 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Luke's Cancer Institute - Boise, 10 "Phase 1" clinical trials were conducted, 191 "Phase 2" clinical trials and 219 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 12 trials that are defined as “Not Applicable".